GEHC vs BIIB — Key Metrics

Metric GEHC (GE HEALTHCARE TECHNOLOGIES INC) BIIB (BIOGEN INC)
Price83.66251.41
Market Cap37.83 Billion37.16 Billion
P/E (TTM)17.65106.53
P/B (Quarterly)2.9521.907
P/S (TTM)1.753.61
Net Profit Margin (TTM)10.03.4
Gross Margin (TTM)39.974.0
ROE (TTM)19.71.9
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

GE HEALTHCARE TECHNOLOGIES INC
vs
 
BIOGEN INC
 
GE HEALTHCARE TECHNOLOGIES INC
vs
 
BIOGEN INC
Performance Comparison
AI Model Recommendation
GEHC · GE HEALTHCARE TECHNOLOGIES INC

Outperform

29
UnderperformOutperform
BIIB · BIOGEN INC

Greatly Outperform

76
UnderperformOutperform
Recommendation Summary

Stock GEHC is projected to outperform the market, stock BIIB is projected to greatly outperform the market. Upfront Recommendation: BIIB.

Financial Metrics
Prices delayed ~15 min
GEHC Metrics BIIB
$83.66 Price $251.41
— Market Capitalization —
17.65 Price to Earnings Ratio 106.53
1.75 Price to Sales 3.61
20.02 Price to FCF Ratio 18.09
4.38 Price to Gross Profit 4.88
28.85 Price to R&D 17.27
3.29 Price to Current Assets 4.9

GEHC vs BIIB at a glance

GE Healthcare Technologies INC (GEHC) and Biogen INC (BIIB) are both in the Healthcare sector. They are similar in size: $37.8 billion and $37.2 billion in market value.

On trailing-twelve-month figures, GEHC trades at 17.6 times trailing earnings and BIIB at 106.5; net profit margins are 10.0% and 3.4%.

The Upfront Investment model currently rates GEHC Outperform and BIIB Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.